GW announces that the regulatory dossier for the Company’s first cannabis-based prescription medicine has been submitted to the UK Medicines Control Agency as planned.
- Ends -
GW Pharmaceuticals pl: (12/12/05) + 44 20 7067 0700
Dr Geoffrey Guy, Chairman
Justin Gover, Managing Director
Weber Shandwick SquareMile: + 44 20 7067 0700
Kevin Smith/Graham Herring